Publications

1. Butterfield J, Weiler CR. The Utility of Measuring Urinary Metabolites of Mast Cell Mediators in Systemic Mastocytosis and Mast Cell Activation Syndrome. J Allergy Clin Immunol Pract. 2020 Sep; 8 (8):2533-2541 Epub 2020 Mar 03
   View PubMed
2. Weiler CR. Mast Cell Activation Syndrome: Tools for Diagnosis and Differential Diagnosis. J Allergy Clin Immunol Pract. 2020 Feb; 8 (2):498-506 Epub 2019 Aug 27
   View PubMed
3. Weiler CR, Austen KF, Akin C, Barkoff MS, Bernstein JA, Bonadonna P, Butterfield JH, Carter M, Fox CC, Maitland A, Pongdee T, Mustafa SS, Ravi A, Tobin MC, Vliagoftis H, Schwartz LB. AAAAI Mast Cell Disorders Committee Work Group Report: Mast cell activation syndrome (MCAS) diagnosis and management. J Allergy Clin Immunol. 2019 Oct; 144 (4):883-896 Epub 2019 Aug 30
   View PubMed
4. Butterfield JH, Kane GC, Weiler CR. Hypereosinophilic syndrome: endomyocardial biopsy versus echocardiography to diagnose cardiac involvement. Postgrad Med. 2017 Jun; 129: (5)517-523.
   View PubMed
5. Patel B, Butterfield JH, Weiler CR, Kane SV. Tolerance and Efficacy with Simultaneous Use of Two Monoclonal Antibodies for a Patient with Hypereosinophilic Syndrome and Ulcerative Colitis. Monoclon Antib Immunodiagn Immunother. 2016 Dec; 35 (6):300-303 Epub 2016 Dec 02
   View PubMed
6. Jin JJ, Butterfield JH, Weiler CR. Hematologic Malignancies Identified in Patients with Hypereosinophilia and Hypereosinophilic Syndromes. J Allergy Clin Immunol Pract. 2015 Nov-Dec; 3: (6)920-5.
   View PubMed
7. Ravi A, Butterfield J, Weiler CR. Mast cell activation syndrome: improved identification by combined determinations of serum tryptase and 24-hour urine 11beta-prostaglandin2alpha. J Allergy Clin Immunol Pract. 2014 Nov-Dec; 2(6):775-8. Epub 2014 Nov 06.
   View PubMed
8. Weiler CR, Butterfield J. Mast cell sarcoma: clinical management. Immunol Allergy Clin North Am. 2014 May; 34(2):423-32. Epub 2014 Mar 13.
   View PubMed
9. Butterfield JH, Weiler CR. Presentation of untreated systemic mastocytosis as recurrent, pulseless-electrical-activity cardiac arrests resistant to cardiac pacemaker. Int Arch Allergy Immunol. 2014; 163 (2):130-4 Epub 2013 Dec 04
   View PubMed
10. Leon-Ferre RA, Weiler CR, Halfdanarson TR. Hypereosinophilic syndrome presenting as an unusual triad of eosinophilia, severe thrombocytopenia, and diffuse arterial thromboses, with good response to mepolizumab. Clin Adv Hematol Oncol. 2013 May; 11(5):317-9.
    View PubMed
11. Butterfield JH, Weiler CR. Systemic mastocytosis in the elderly. Am J Hematol. 2013 May; 88(5):406-8. Epub 2013 Mar 27.
    View PubMed
12. Elias MK, Mateen FJ, Weiler CR. The Melkersson-Rosenthal syndrome: a retrospective study of biopsied cases. J Neurol. 2013 Jan; 260 (1):138-43 Epub 2012 July 27
    View PubMed
13. Sridhara S, Ravi K, Smyrk TC, Kita H, Kephart GM, Weiler CR, Katzka DA. Increased numbers of eosinophils, rather than only etiology, predict histologic changes in patients with esophageal eosinophilia. Clin Gastroenterol Hepatol. 2012 Jul; 10(7):735-41. Epub 2012 Jan 28.
    View PubMed
14. Bleeker JS, Syed FF, Cooper LT, Weiler CR, Tefferi A, Pardanani A. Treatment-refractory idiopathic hypereosinophilic syndrome: pitfalls and progress with use of novel drugs. Am J Hematol. 2012 Jul; 87 (7):703-6 Epub 2012 Feb 24
    View PubMed
15. Arora AA, Weiler CR, Katzka DA. Eosinophilic esophagitis: allergic contribution, testing, and management. Curr Gastroenterol Rep. 2012 Jun; 14 (3):206-15
    View PubMed
16. Butterfield JH, Weiler CR. Treatment of hypereosinophilic syndromes--the first 100 years. Semin Hematol. 2012 Apr; 49 (2):182-91
    View PubMed
17. Butterfield JH, Weiler CR. Use of pegylated interferon in hypereosinophilic syndrome. Leuk Res. 2012 Feb; 36 (2):192-7 Epub 2011 Nov 26
    View PubMed
18. Lee J, Dierkhising R, Wu TT, Alexander J, Weiler C. Eosinophilic gastrointestinal disorders (EGID) with peripheral eosinophilia: a retrospective review at Mayo Clinic. Dig Dis Sci. 2011 Nov; 56 (11):3254-61 Epub 2011 June 08
    View PubMed
19. Butterfield JH, Weiler CR. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production. Int Arch Allergy Immunol. 2008; 147(4):338-43. Epub 2008 Jul 12.
    View PubMed
20. Swoger JM, Weiler CR, Arora AS. Eosinophilic esophagitis: is it all allergies? Mayo Clin Proc. 2007 Dec; 82 (12):1541-49
    View PubMed
21. Cheng YK, Decker PA, O'Byrne MM, Weiler CR. Clinical and laboratory characteristics of 75 patients with specific polysaccharide antibody deficiency syndrome. Ann Allergy Asthma Immunol. 2006 Sep; 97(3):306-11.
    View PubMed
22. Karakelides M, Monson KL, Volcheck GW, Weiler CR. Monoclonal gammopathies and malignancies in patients with chronic urticaria. Int J Dermatol. 2006 Sep; 45(9):1032-8.
    View PubMed
23. Weiler CR, van Dellen RG. Genetic test indications and interpretations in patients with hereditary angioedema. Mayo Clin Proc. 2006 Jul; 81(7):958-72.
    View PubMed
24. Orange JS, Hossny EM, Weiler CR, Ballow M, Berger M, Bonilla FA, Buckley R, Chinen J, El-Gamal Y, Mazer BD, Nelson RP Jr, Patel DD, Secord E, Sorensen RU, Wasserman RL, Cunningham-Rundles C, Primary Immunodeficiency Committee of the American Academy of Allergy Asthma and Immunology. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol. 2006 Apr; 117(4 Suppl):S525-53.
    View PubMed
25. Weiler CR, Bankers-Fulbright JL. Common variable immunodeficiency: test indications and interpretations. Mayo Clin Proc. 2005 Sep; 80(9):1187-200.
    View PubMed
26. Babovic-Vuksanovic D, Jacobson RM, Lindor NM, Weiler CR. Selective antibody immune deficiency in a patient with Smith-Lemli-Opitz syndrome. J Inherit Metab Dis. 2005; 28 (2):181-6
    View PubMed
27. Eberhart AH, Weiler CR, Erie JC. Angioedema related to the use of hyaluronidase in cataract surgery. Am J Ophthalmol. 2004 Jul; 138(1):142-3.
    View PubMed
28. Weiler CR. Immunoglobulin therapy: history, indications, and routes of administration. Int J Dermatol. 2004 Mar; 43 (3):163-6
    View PubMed
29. Phy JL, Weiss WT, Weiler CR, Damario MA. Hypersensitivity to progesterone-in-oil after in vitro fertilization and embryo transfer. Fertil Steril. 2003 Nov; 80 (5):1272-5
    View PubMed
30. Papouchado BG, Chapoval SP, Marietta EV, Weiler CR, David CS. Cockroach allergen-induced eosinophilic airway inflammation in HLA-DQ/human CD4(+) transgenic mice. J Immunol. 2001 Oct 15; 167 (8):4627-34
    View PubMed
31. Thomas LL, Kubo H, Loegering DJ, Spillard K, Weaver AJ, McCormick DJ, Weiler C, Gleich GJ. Peptide-based analysis of amino acid sequences important to the biological activity of eosinophil granule major basic protein. Immunol Lett. 2001 Oct 1; 78(3):175-81.
    View PubMed
32. Steensma DP, Tefferi A, Weiler CR. Autoimmune hemolytic anemia in a patient with autosomal dominant chronic mucocutaneous candidiasis. Mayo Clin Proc. 2000 Aug; 75(8):853-5.
    View PubMed
33. Papouchado BG, Chapoval SP, Marietta EV, Weiler CR, David CS. HLA-DQ/human CD4-restricted immune response to cockroach allergens in transgenic mice. Tissue Antigens. 2000 Apr; 55 (4):303-11
    View PubMed
34. Kubo H, Loegering DA, Tohda Y, Bankers-Fulbright J, Bankers-Fulbright J, Weiler CR, Nakajima H, Thomas LL, Adolphson CR, Gleich GJ. Discordant and anomalous results among cytotoxicity assays: the confounding properties of eosinophil granule major basic protein on cell viability assays. J Immunol Methods. 1999 Jul 30; 227 (1-2):1-15
    View PubMed
35. Weiler CR, Kita H, Hukee M, Gleich GJ. Eosinophil viability during immunoglobulin-induced degranulation. J Leukoc Biol. 1996 Oct; 60 (4):493-501
    View PubMed
36. Kita H, Abu-Ghazaleh RI, Sur S, Gleich GJ. Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils. J Immunol. 1995 May 1; 154(9):4749-58.
    View PubMed
37. Murray MJ, Strickland RA, Weiler C. The use of neuromuscular blocking drugs in the intensive care unit: a US perspective. Intensive Care Med. 1993; 19 Suppl 2:S40-4
    View PubMed
38. Abu-Ghazaleh RI, Dunnette SL, Abu-Ghazaleh RI, Loegering DA, Checkel JL, Kita H, Thomas LL, Gleich GJ. Eosinophil granule proteins in peripheral blood granulocytes. J Leukoc Biol. 1992 Dec; 52 (6):611-8
    View PubMed
39. Kita H, Weiler DA, Abu-Ghazaleh R, Sanderson CJ, Gleich GJ. Release of granule proteins from eosinophils cultured with IL-5. J Immunol. 1992 Jul 15; 149 (2):629-35
    View PubMed
40. Abu-Ghazaleh RI, Abu-Ghazaleh RI, Gleich GJ, Prendergast FG. Interaction of eosinophil granule major basic protein with synthetic lipid bilayers: a mechanism for toxicity. J Membr Biol. 1992 Jun; 128 (2):153-64
    View PubMed
41. Abu-Ghazaleh RI, Kita H, Gleich GJ. Eosinophil activation and function in health and disease. Immunol Ser. 1992; 57:137-67.
    View PubMed
42. Kita H, Abu-Ghazaleh RI, Gleich GJ, Abraham RT. Role of pertussis toxin-sensitive G proteins in stimulus-dependent human eosinophil degranulation. J Immunol. 1991 Nov 15; 147(10):3466-73.
    View PubMed
43. Kita H, Abu-Ghazaleh RI, Gleich GJ, Abraham RT. Regulation of Ig-induced eosinophil degranulation by adenosine 3',5'-cyclic monophosphate. J Immunol. 1991 Apr 15; 146(8):2712-8.
    View PubMed
44. Kita H, Abu-Ghazaleh R, Sanderson CJ, Abu-Ghazaleh R, Gleich GJ. Effect of steroids on immunoglobulin-induced eosinophil degranulation. J Allergy Clin Immunol. 1991 Jan; 87 (1 Pt 1):70-7
    View PubMed
45. Fujisawa T, Abu-Ghazaleh R, Kita H, Sanderson CJ, Gleich GJ. Regulatory effect of cytokines on eosinophil degranulation. J Immunol. 1990 Jan 15; 144 (2):642-6
    View PubMed
46. Abu-Ghazaleh RI, Fujisawa T, Mestecky J, Kyle RA, Gleich GJ. IgA-induced eosinophil degranulation. J Immunol. 1989 Apr 1; 142(7):2393-400.
    View PubMed
47. Fujisawa T, Uchida Y, Abu-Ghazaleh RI, Gleich GJ. The effect of cytokines on eosinophil degranulation. 38th Annual Meeting Japanese Society of Allergology Kyoto Japan. 1988.